Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Marschalek

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Blood|August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Leukemia|March 23, 2019
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusionsClaus Meyer, Bruno A Lopes, Aurélie Caye-Eude, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Blood|August 2, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expressionBelén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Blood|August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Leukemia|March 23, 2019
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusionsClaus Meyer, Bruno A Lopes, Aurélie Caye-Eude, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Blood|August 2, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expressionBelén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Pageof 19